Intrinsic Value of S&P & Nasdaq Contact Us

Day One Biopharmaceuticals, Inc. DAWN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$23.75
+10.7%

Day One Biopharmaceuticals, Inc. (DAWN) has 8 identified peers for comparison in the Healthcare sector. Peers include ABOS, ELDN, HOOK, INZY, MREO, PDSB and others.

DAWN has a market capitalization of $2.22B, compared to an average peer market cap of $691.42M. DAWN is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message